4.6 Article

NMR analysis seeking for cognitive decline and dementia metabolic markers in plasma from aged individuals

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Nutrition & Dietetics

Branched-Chain Amino Acids and Insulin Resistance, from Protein Supply to Diet-Induced Obesity

Jean-Pascal De Bandt et al.

Summary: There has been a long-standing debate on the effects of branched-chain amino acids (BCAA), specifically leucine, valine, and isoleucine, with some claiming their anabolic effects and others suggesting a link to insulin resistance. The role of leucine in protein synthesis after a meal has been established, although attempts to harness this property through supplementation have had disappointing results. Evidence suggests that elevated plasma levels of BCAAs are associated with insulin resistance and the development of type 2 diabetes, but other factors such as animal protein consumption may confound the relationship. This review analyzes factors that can increase BCAA plasma concentrations, including insulin resistance, and discusses the indirect role of BCAA metabolites in insulin resistance.

NUTRIENTS (2023)

Review Nutrition & Dietetics

The contradictory role of branched-chain amino acids in lifespan and insulin resistance

He Yao et al.

Summary: Branched-chain amino acids (BCAAs) play important regulatory roles in glucose and lipid metabolism, protein synthesis, and longevity. Studies have shown associations between circulating BCAA levels or dietary intake of BCAAs and longevity, sarcopenia, obesity, and diabetes. However, the effects of BCAAs on aging and insulin resistance vary in different populations, and contradictory conclusions have been drawn. The regulatory mechanism may be related to endogenous BCAA levels, BCAA metabolism, mTOR-related autophagy, and the recent discovery that insulin resistance may be independent of longevity.

FRONTIERS IN NUTRITION (2023)

Review Cell Biology

Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives

Simone Lista et al.

Summary: Alzheimer's disease (AD) is determined by various pathophysiological mechanisms starting 10-25 years before the onset of clinical symptoms. Metabolomics, a rapidly developing discipline, can detect and quantify hundreds/thousands of perturbed metabolites, reproducing the fluctuations of multiple networks affected by a disease. Metabolomics can help identify potential biomarkers and elucidate the pathophysiological mechanisms of AD.

AGEING RESEARCH REVIEWS (2023)

Article Medicine, General & Internal

Plasma metabolomic profiles of dementia: a prospective study of 110,655 participants in the UK Biobank

Xinyu Zhang et al.

Summary: This study identified various metabolomic biomarkers that are significantly associated with incident dementia. It was found that adding these metabolites to the conventional risk prediction model improved the prediction for incident dementia and reclassification ability.

BMC MEDICINE (2022)

Article Neurosciences

Acute Methylglyoxal-Induced Damage in Blood-Brain Barrier and Hippocampal Tissue

Lilian Juliana Lissner et al.

Summary: By administering methylglyoxal to rats, it was found that it could cause damage to the blood-brain barrier and alterations in astrocyte response in the hippocampus, which may contribute to behavioral and cognitive changes in animals.

NEUROTOXICITY RESEARCH (2022)

Article Clinical Neurology

Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches

Chun-Hung Chang et al.

Summary: Peripheral plasma d-glutamate levels were found to be associated with cognitive impairment and may serve as a suitable biomarker for detecting MCI and AD. Machine learning algorithms and HPLC technology can assist physicians in outpatient clinics to diagnose MCI and AD more effectively.

JOURNAL OF PSYCHOPHARMACOLOGY (2021)

Article Multidisciplinary Sciences

Whole-blood metabolomics of dementia patients reveal classes of disease-linked metabolites

Takayuki Teruya et al.

Summary: Dementia patients show significant differences in 33 metabolites in whole blood, with seven potential neurotoxins present and other compounds that may decrease brain protection. Several metabolites enriched in red blood cells decrease in dementia patients, including potent antioxidants. Metabolites normally protecting the brain in plasma are diminished in dementia, which may contribute to decreased brain function.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Endocrinology & Metabolism

The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

Ygor Parladore Silva et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Review Clinical Neurology

Alzheimer's disease

C. A. Lane et al.

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Medicine, Research & Experimental

Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia

Bruno Peixoto et al.

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

Branched-Chain Amino Acids and Brain Metabolism

Justin E. Sperringer et al.

NEUROCHEMICAL RESEARCH (2017)

Article Clinical Neurology

Metabolic network failures in Alzheimer's disease: A biochemical road map

Jon B. Toledo et al.

ALZHEIMERS & DEMENTIA (2017)

Article Biochemistry & Molecular Biology

NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls

Joao Figueira et al.

MOLECULAR BIOSYSTEMS (2016)

Article Biotechnology & Applied Microbiology

Neuroprotective Effects of Clostridium butyricum against Vascular Dementia in Mice via Metabolic Butyrate

Jiaming Liu et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Biotechnology & Applied Microbiology

Role of Methylglyoxal in Alzheimer's Disease

Cristina Angeloni et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Multidisciplinary Sciences

The Human Serum Metabolome

Nikolaos Psychogios et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects

A. N. Fonteh et al.

AMINO ACIDS (2007)

Article Nutrition & Dietetics

Branched-chain amino acids and brain function

JD Fernstrom

JOURNAL OF NUTRITION (2005)

Article Biochemistry & Molecular Biology

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation

E Le Poul et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Review Biochemistry & Molecular Biology

On the mammalian acetone metabolism: from chemistry to clinical implications

MP Kalapos

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)